Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
NYS Entity Status
NYS Filing Date
APRIL 16, 2014
NYS DOS ID#
SPIEGEL & UTRERA, P.A. P.C.
1 MAIDEN LANE
NEW YORK, NEW YORK, 10038
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - A & S CONTRACTORS LLC
Around the Web
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
- Russian hackers stole classified data from NSA contractor
By Bob Fredericks - Thursday Oct 5, 2017
Russian government hackers stole data about how the US penetrates foreign computer networks and defends against cyberattacks after a National Security Agency contractor removed highly classified material and stashed it on his home computer, a new report said Thursday. The hackers apparently targeted the contractor after identifying the files through the contractor’s use of an...
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- White House might lean on private contractors for Afghan war
By Mark Moore - Tuesday Aug 8, 2017
The White House is considering turning to private military contractors to carry out the bulk of the war in Afghanistan, according to a report on Tuesday. Erik Prince, an ex-Navy SEAL and the former founder of the security firm Blackwater, told USA Today that his proposal would involve about 5,500 private contractors – mainly former...
- The Look: New York City Parks in the Summer: Romance, Games and a Performance for a Dying Tree
By DANIEL ARNOLD, JOANNA NIKAS and EVE LYONS - Saturday Sep 2, 2017
Daniel Arnold spent the last two months photographing parks in all five boroughs. The experience showed him “a very different pulse of the city.”
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]